BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 15016838)

  • 1. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
    Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.
    Wang D; Simons SS
    Mol Endocrinol; 2005 Jun; 19(6):1483-500. PubMed ID: 15774497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression.
    Szapary D; Huang Y; Simons SS
    Mol Endocrinol; 1999 Dec; 13(12):2108-21. PubMed ID: 10598585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of induction properties of glucocorticoid receptor-agonist and -antagonist complexes by coactivators involves binding to receptors but is independent of ability of coactivators to augment transactivation.
    He Y; Szapary D; Simons SS
    J Biol Chem; 2002 Dec; 277(51):49256-66. PubMed ID: 12376547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
    Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
    Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors.
    Wang D; Wang Q; Awasthi S; Simons SS
    Biochemistry; 2007 Jul; 46(27):8036-49. PubMed ID: 17571860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
    Stevens A; Garside H; Berry A; Waters C; White A; Ray D
    Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
    Ki SH; Cho IJ; Choi DW; Kim SG
    Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
    Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
    Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Ralpha from a negative hormone response element.
    Berghagen H; Ragnhildstveit E; Krogsrud K; Thuestad G; Apriletti J; Saatcioglu F
    J Biol Chem; 2002 Dec; 277(51):49517-22. PubMed ID: 12388540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
    Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
    Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
    Cho S; Blackford JA; Simons SS
    Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
    Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
    Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding.
    Schulz M; Eggert M; Baniahmad A; Dostert A; Heinzel T; Renkawitz R
    J Biol Chem; 2002 Jul; 277(29):26238-43. PubMed ID: 12011091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure/activity elements of the multifunctional protein, GMEB-1. Characterization of domains relevant for the modulation of glucocorticoid receptor transactivation properties.
    Chen J; Kaul S; Simons SS
    J Biol Chem; 2002 Jun; 277(24):22053-62. PubMed ID: 11934901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of transcription parameters in glucocorticoid receptor-mediated repression.
    Sun Y; Tao YG; Kagan BL; He Y; Simons SS
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):59-69. PubMed ID: 18583028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC; Astapova I; Hollenberg AN; Balk SP
    Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.